| 000 | 01355 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515020756.0 | ||
| 264 | 0 | _c20060710 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a1174-5886 | ||
| 024 | 7 |
_a10.2165/00126839-200607020-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarten, Donna M | |
| 245 | 0 | 0 |
_aGamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity. _h[electronic resource] |
| 260 |
_bDrugs in R&D _c2006 |
||
| 300 |
_a87-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aAmyloid Precursor Protein Secretases |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAspartic Acid Endopeptidases |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 |
_aEndopeptidases _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aProtease Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aReceptors, Notch _xphysiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMeredith, Jere E | |
| 700 | 1 | _aZaczek, Robert | |
| 700 | 1 | _aHouston, John G | |
| 700 | 1 | _aAlbright, Charles F | |
| 773 | 0 |
_tDrugs in R&D _gvol. 7 _gno. 2 _gp. 87-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00126839-200607020-00003 _zAvailable from publisher's website |
| 999 |
_c16150684 _d16150684 |
||